Image Place holder

Jad Chahoud, MD


Specialty: Hematology/Oncology
Program: Genitourinary Oncology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)

Overview

Cancer Types Treated: Prostate Cancer , Testicular Cancer , Kidney (Renal Cell) Cancer , Penile Cancer

Dr. Chahoud completed his Internal Medicine Residency at the University of Texas Health Science Center and completed his Hematology and Medical Oncology Fellowship at the University of Texas MD Anderson Cancer Center in Houston. Dr. Chahoud's clinical expertise includes advanced stage genitourinary malignancies, with a specific focus on advanced kidney and penile cancer. Dr. Chahoud's research aims to understand the role of viral infections and the immune microenvironment in genitourinary cancers. He received funding from the Conquer Cancer Foundation through the ASCO Young Investigator Award in 2018 to study viral and immune biomarkers for metastasis and poor survival in penile squamous cell carcinoma. His research interest is focused on providing precision care through biomarker research to determine the most effective treatment strategy, and the investigation of novel therapies for patients with advanced renal, prostate, testicular and penile cancer.

Education & Training

Board Certification:

  • Internal Medicine

Fellowship:

  • University of Texas MD Anderson Cancer Center -

Residency:

  • University of Texas Health Science Center -

Medical School:

  • Lebanese University Faculty of Medical Sciences - MD
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Chahoud J, Pickering CR, Pettaway CA. Genetics and penile cancer: recent developments and implications. Curr Opin Urol. 2019 Jul;29(4):364-370. Pubmedid: 31045928.
  • Chahoud J, Zhang M, Pisters LL, Lin SC, Lin SH, Tu SM. Identification of Glypican-3 (GPC3) Expression in a Lethal Subgroup of Refractory Cisplatin-Resistant Testicular Germ-Cell Tumors. Clin Genitourin Cancer. 2018 Oct;16(5):325-327. Pubmedid: 29807831.
  • Chahoud J, Zhang M, Shah A, Lin SH, Pisters LL, Tu SM. Managing seminomatous and nonseminomatous germ cell tumors. Curr Opin Oncol. 2018 May;30(3):181-188. Pubmedid: 29538040.
  • Chahoud J, Sui D, Erwin WD, Gulbis AM, Korbling M, Zhang M, Ahmed S, Alatrash G, Anderlini P, Ciurea SO, Oran B, Fayad LE, Bassett RL, Jabbour EJ, Medeiros LJ, Macapinlac HA, Young KH, Khouri IF. Updated Results of Rituximab Pre- and Post-BEAM with or without Yttrium Ibritumomab Tiuxetan during Autologous Transplant for Diffuse Large B-cell Lymphoma. Clin Cancer Res. 2018 May;24(10):2304-2311. Pubmedid: 29476021. Pmcid: PMC5955837.
  • Chahoud J, Rieber AG, Tyring SK. The β-HPV Subtypes-Cornerstone of the Next-Generation Vaccine. JAMA Oncol. 2017 May;3(5):594-595. Pubmedid: 27893031.
  • Chahoud J, Sharif Yakan A, Saad H, Kanj SS. Right-Sided Infective Endocarditis and Pulmonary Infiltrates: An Update. Cardiol Rev. 2016 Sep;24(5):230-237. Pubmedid: 26501991.
  • Chahoud J, Semaan A, Chen Y, Cao M, Rieber AG, Rady P, Tyring SK. Association Between β-Genus Human Papillomavirus and Cutaneous Squamous Cell Carcinoma in Immunocompetent Individuals-A Meta-analysis. JAMA Dermatol. 2016 Dec;152(12):1354-1364. Pubmedid: 26720285.
  • Chahoud J, Semaan A, Almoosa KF. Ventilator-associated events prevention, learning lessons from the past: A systematic review. Heart Lung. 2015 May;44(3):251-259. Pubmedid: 25686517.
  • Chahoud J, Mrad J, Semaan A, Asmar R. PREVALENCE OF DIABETES MELLITUS AMONG PATIENTS WITH ESSENTIAL ARTERIAL HYPERTENSION. J Med Liban. 2015 Apr;63(2):74-80. Pubmedid: 26164975.
  • Chahoud J, Kanafani Z, Kanj SS. Surgical site infections following spine surgery: eliminating the controversies in the diagnosis. Front Med (Lausanne). 2014 Mar;1:7. Pubmedid: 25705620. Pmcid: PMC4335387.
  • Chahoud J, Kanafani ZA, Kanj SS. Management of candidaemia and invasive candidiasis in critically ill patients. Int J Antimicrob Agents. 2013 Jun;42 Suppl:S29-S35. Pubmedid: 23664579.